Table 1:
Demographic, radiological, biochemical, surgical and pathology examination characteristics of patients undergoing adrenalectomy
| Patient | Sex/Age at adrenal lesion diagnosis | Morphology/Size | Indication for surgery | Treatment timing | Functional status | Surgical approach | Pathology | Outcome |
|---|---|---|---|---|---|---|---|---|
| 1 | Male/29 | Single nodule/80 mm | Pheochromocytoma | Upfront surgery | Functioning (Pheochromocytoma) | Open anterior total adrenalectomy | Pheochromocytoma/adrenocortical hyperplasia | No pheochromocytoma recurrence at 2-year follow-up |
| 2 | Male/54 | Single nodule/123 mm | Adrenocortical carcinoma | Upfront surgery | Functioning (Hyperandrogenism) | Open anterior total adrenalectomy | Adrenocortical carcinoma | Death by metastatic disease at 5-year follow-up |
| 3 | Male/24 | - Left: single nodule/21 mm - Right: Single nodule/15 mm |
-Left: size 21 mm -Right: Nodule hypervascularity |
Left: Upfront surgery Right: Follow-up |
Nonfunctioning | Left: Open anterior total adrenalectomy Right: Open anterior cortical-sparing adrenalectomy |
-Left: Nodular hyperplasia -Right: Adrenocortical hyperplasia |
-Left: 14-year follow-up without recurrence -Right: 6-year follow-up without recurrence |
| 4 | Female/52 | Single nodule/28 mm | Size and concomitant planned distal pancreatectomy | Upfront surgery | Nonfunctioning | Open anterior total adrenalectomy | Adrenocortical adenoma | 5-year follow-up without recurrence |
| 5 | Male/58 | Single nodule/62 mm | pNET extension | Upfront surgery | Not evaluated | Open anterior total adrenalectomy | Invasive pNET | 11-year follow-up without recurrence |
| 6 | Female/43 | Single nodule/33 mm | Enlargement | Follow-up | Nonfunctioning | Retroperitoneoscopic total adrenalectomy | Adrenal cortical neoplasm with oncocytic features, Ki-67 index 12.5% | 7-months follow-up without recurrence |
| 7 | Male/48 | Single nodule/63 mm | Enlargement | Follow-up | Nonfunctioning | Open anterior total adrenalectomy | Adrenocortical carcinoma | 1-year follow-up without recurrence |
| 8 | Female/31 | Single nodule/40 mm | Pheochromocytoma | Upfront surgery | Functioning (Pheochromocytoma) | Open anterior total adrenalectomy | Pheochromocytoma | 8-year follow-up without pheochromocytoma recurrence, death by metastatic gastrinoma |
| 9 | Male/44 | Bilateral hyperplasia | Medical treatment failure | Follow-up | Functioning (ACTH dependent hypercortisolism) | Retroperitoneoscopic bilateral adrenalectomy | Bilateral adrenal cortical hyperplasia | 1-year follow-up with hypercortisolism resolution. Death by metastatic thymic neuroendocrine tumor |
| 10 | Male/56 | Bilateral hyperplasia | Medical treatment failure | Follow-up | Functioning (ACTH dependent hypercortisolism) |
Anterior laparoscopic, converted to open anterior, bilateral adrenalectomy | Bilateral adrenal cortical hyperplasia | Death by postoperative pulmonary complications |
| 11 | Male/51 | Single nodule/76 mm | Size | Upfront surgery | Not evaluated | Anterior laparoscopic total adrenalectomy | Adrenal gland cyst | |
| 12 | Female/32 | -Left: Single nodule/31 mm -Right: Single nodule/20 mm |
Enlargement | Follow-up | Nonfunctioning | -Left: Anterior laparoscopic total adrenalectomy -Right: Anterior laparoscopic total adrenalectomy |
-Left: Atypical myxoid adrenal cortical neoplasm -Right: Atypical myxoid adrenal cortical neoplasm |
-Left: 5-year follow-up without recurrence -Right: 1-year follow-up without recurrence |
pNET, pancreatic neuroendocrine tumor